Literature DB >> 8092562

Changing asthma mortality.

R M Sly1.   

Abstract

BACKGROUND: Rates of death from asthma in the United States have increased progressively since 1978.
OBJECTIVE: To identify recent trends in asthma mortality.
METHODS: The National Center for Health Statistics supplied asthma mortality data (ICD 493), and the Bureau of the Census supplied population data that permitted calculation and graphing of mortality data by age group, race, sex, and region and calculation and tabulation of mortality rates by state. The Departments of Health and Vital Statistics of Australia, Canada, Great Britain, and New Zealand provided data that permitted calculation and graphing of rates of death from asthma (ICD 493) in those countries.
RESULTS: Rates of death from asthma in the United States increased from 0.8 per 100,000 in 1977 and 1978 to 2.0 in 1989, fell to 1.9 in 1990 and then increased again to 2.0 in 1991. Rates have been much higher for blacks than whites; age-adjusted rates for blacks increased from 1.5 in 1977 and 1978 to 3.5 in 1991; those for whites, from 0.5 in 1977 to 1.2 in 1991. Rates of death from asthma have increased with age and across time have increased in almost all age groups. The greatest proportional increase has occurred at 10 to 14 years of age with rates of 0.1 in 1979, 0.5 in 1987, and 0.4 in 1991. Rates of death at 5 through 34 years of age have increased for both blacks and whites in all regions of the country. Increases in rates of death from asthma have also occurred in other countries, but rates have been falling in New Zealand since the peak of 8.1 in 1980 and in Australia since the peak of 5.7 in 1989.
CONCLUSIONS: The recent plateau in increases in rates of death from asthma in the United States may suggest effectiveness of improved management of asthma that may have followed increased awareness of the importance of optimal management.

Entities:  

Mesh:

Year:  1994        PMID: 8092562

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  8 in total

1.  Understanding the costs of asthma: the next step.

Authors:  K B Weiss; S D Sullivan
Journal:  CMAJ       Date:  1996-03-15       Impact factor: 8.262

Review 2.  Inhaled corticosteroids in childhood asthma: growing concerns.

Authors:  K B Witzmann; R J Fink
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 3.  Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

Authors:  D H Peters; D Faulds
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 4.  Late onset asthma: epidemiology, diagnosis and treatment.

Authors:  B T Kitch; B D Levy; C H Fanta
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

5.  Sex differences in the use of asthma drugs: cross sectional study.

Authors:  M Sexton; M D Althuis; N Santanello; S Hyndman; R Williams; D Schmeidler
Journal:  BMJ       Date:  1998-11-21

6.  Characteristics of allergic sensitization among asthmatic adults older than 55 years: results from the National Health and Nutrition Examination Survey, 2005-2006.

Authors:  Paula J Busse; Richard D Cohn; Paivi M Salo; Darryl C Zeldin
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02-13       Impact factor: 6.347

Review 7.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Latex allergens in tire dust and airborne particles.

Authors:  A G Miguel; G R Cass; J Weiss; M M Glovsky
Journal:  Environ Health Perspect       Date:  1996-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.